Marco Picchi
Marco Picchi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Elio Rossi
Tuscany Regional Homeopathic Reference Centre, Homeopathic Clinic of Campo di Marte Hospital, Local Health Authority North West, Lucca, Italy
2 shared publications - Antonella Traversi
Tuscan Regional Centre for Integrative Medicine, Region of Tuscany, 50100 Florence, Italy
1 shared publication - Catia Vuono
Tuscan Regional Centre for Integrative Medicine, Region of Tuscany, 50100 Florence, Italy
1 shared publication - Fabio Firenzuoli
CERFIT, Research and Innovation Center in Phytotherapy and Integrated Medicine, Careggi University Hospital, 50134 Florence, Italy
1 shared publication - Federica Sabatini
Tuscan Regional Centre for Integrative Medicine, Region of Tuscany, 50100 Florence, Italy
1 shared publication - Linda Nurra
Ambulatorio di omeopatia Padiglione B Cittadella della Salute-Ospedale Campo di Marte 55100 Lucca Italy
1 shared publication
Latest Publications
- Open Access
- 20 June 2019
- Published by LIDSEN Publishing Inc in OBM Integrative and Complementary Medicine
- Vol. 04 (02) , 1-12
Preliminary Long-Term Results of Homeopathic Treatment of Atopic Diseases in Adult Patients
Aim: To study the effect of homeopathic treatment on adult patients with atopic diseases visited at the Homeopathic Clinic of Lucca (Italy) and long-term evolution of the disease over approximately an 8-year period. Materials and Methods: Data derive from an observational longitudinal study carried out on 563 atopic adult patients who were consecutively visited from 1998 to 2017; 202 (35.9%) suffered from atopic dermatitis, 204 (36.2%) from allergic rhinitis, and 157 (27.9%) from asthma. Moreover, a long-term study was conducted on a subset of 45/104 adult patients, consecutively visited from 2006 to 2012, and with ≥ 5 years follow-up. The study also investigated the evolution of overall symptoms in those patients with a complex atopic symptomatology. Results: 69.3% of atopic adults had moderate or major improvement (71.1% with asthma as the primary disease; 69.8% rhinitis; 67.1% dermatitis). At re-evaluation after 5-12 years, complete remission of atopic symptoms was observed in 69.6% of adult patients: 100% in dermatitis; 59.2% in allergic rhinitis, 75% in asthma. Adult patients with more than one atopic diseases at the first visit were completely cured in 54.3% of cases. Conclusion: The results seem to confirm that homeopathic medicine produces positive therapeutic response also in adult atopic patients.
- 20 June 2019
- Published by LIDSEN Publishing Inc in OBM Integrative and Complementary Medicine
- Vol. 04 (02) , 1-12
Open AccessPreliminary Long-Term Results of Homeopathic Treatment of Atopic Diseases in Adult Patients
Aim: To study the effect of homeopathic treatment on adult patients with atopic diseases visited at the Homeopathic Clinic of Lucca (Italy) and long-term evolution of the disease over approximately an 8-year period. Materials and Methods: Data derive from an observational longitudinal study carried out on 563 atopic adult patients who were consecutively visited from 1998 to 2017; 202 (35.9%) suffered from atopic dermatitis, 204 (36.2%) from allergic rhinitis, and 157 (27.9%) from asthma. Moreover, a long-term study was conducted on a subset of 45/104 adult patients, consecutively visited from 2006 to 2012, and with ≥ 5 years follow-up. The study also investigated the evolution of overall symptoms in those patients with a complex atopic symptomatology. Results: 69.3% of atopic adults had moderate or major improvement (71.1% with asthma as the primary disease; 69.8% rhinitis; 67.1% dermatitis). At re-evaluation after 5-12 years, complete remission of atopic symptoms was observed in 69.6% of adult patients: 100% in dermatitis; 59.2% in allergic rhinitis, 75% in asthma. Adult patients with more than one atopic diseases at the first visit were completely cured in 54.3% of cases. Conclusion: The results seem to confirm that homeopathic medicine produces positive therapeutic response also in adult atopic patients.
- Open Access
Patient Safety in Complementary Medicine through the Application of Clinical Risk Management in the Public Health System
Aim: To develop a systematic approach to detect and prevent clinical risks in complementary medicine (CM) and increase patient safety through the analysis of activities in homeopathy and acupuncture centres in the Tuscan region using a significant event audit (SEA) and failure modes and effects analysis (FMEA). Methods: SEA is the selected tool for studying adverse events (AE) and detecting the best solutions to prevent future incidents in our Regional Healthcare Service (RHS). This requires the active participation of all the actors and external experts to validate the analysis. FMEA is a proactive risk assessment tool involving the selection of the clinical process, the input of a multidisciplinary group of experts, description of the process, identification of the failure modes (FMs) for each step, estimates of the frequency, severity, and detectability of FMs, calculation of the risk priority number (RPN), and prioritized improvement actions to prevent FMs. Results: In homeopathy, the greatest risk depends on the decision to switch from allopathic to homeopathic therapy. In acupuncture, major problems can arise, mainly from delayed treatment and from the modalities of needle insertion. Conclusions: The combination of SEA and FMEA can reveal potential risks for patients and suggest actions for safer and more reliable services in CM.
Open AccessPatient Safety in Complementary Medicine through the Application of Clinical Risk Management in the Public Health System
Aim: To develop a systematic approach to detect and prevent clinical risks in complementary medicine (CM) and increase patient safety through the analysis of activities in homeopathy and acupuncture centres in the Tuscan region using a significant event audit (SEA) and failure modes and effects analysis (FMEA). Methods: SEA is the selected tool for studying adverse events (AE) and detecting the best solutions to prevent future incidents in our Regional Healthcare Service (RHS). This requires the active participation of all the actors and external experts to validate the analysis. FMEA is a proactive risk assessment tool involving the selection of the clinical process, the input of a multidisciplinary group of experts, description of the process, identification of the failure modes (FMs) for each step, estimates of the frequency, severity, and detectability of FMs, calculation of the risk priority number (RPN), and prioritized improvement actions to prevent FMs. Results: In homeopathy, the greatest risk depends on the decision to switch from allopathic to homeopathic therapy. In acupuncture, major problems can arise, mainly from delayed treatment and from the modalities of needle insertion. Conclusions: The combination of SEA and FMEA can reveal potential risks for patients and suggest actions for safer and more reliable services in CM.